SCHEMBL20176502

SCHEMBL20176502

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)nc4)c4ccccc34)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ATM Q13315 1/20 0.45
KMT2A Q03164 2/20 0.39
PTGER4 P35408 1/20 0.35
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
IL1R1 P14778 1/20 0.34
TSPO P30536 1/20 0.34
HDAC4 P56524 1/20 0.34
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
RAC2 P15153 1/20 0.33
RAC3 P60763 1/20 0.33
CDC42 P60953 1/20 0.33
RAC1 P63000 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26160948 0.99 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL26160951 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL20176537 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL26161216 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL20176489 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AHSD17B1
SCHEMBL26161219 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL26161037 0.93 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL26161034 0.91 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL26160946 0.91 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2AHSD17B1
SCHEMBL20176540 0.91 ESR1 (0.37) L3MBTL1KDM4EATMKMT2AHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 L3MBTL1 869/4885KDM4E 2080/4885ATM 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.